Concentrix Corporation CNXC R3KTECHAI
Company Overview
Concentrix Corporation designs, builds, and runs integrated customer experience (CX) solutions worldwide. It provides CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics, and business transformation services to clients in various industry verticals comprising technology and consumer electronics; retail, travel, and e-commerce; communications and media; banking, financial services, and insurance; and healthcare. The company also offers customer lifecycle management; CX and user experience strategy and design; data analytics, enterprise intelligence, artificial intelligence readiness, and actionable insights; digital operations, such as B2B sales, performance marketing, customer loyalty, trust and safety, collections, and financial compliance; and GenAI and agentic AI technologies. In addition, it provides digital transformation services that designs and engineer CX solutions to enable efficient customer self-service and build customer loyalty; customer engagement solutions and services that address the entirety of the customer lifecycle; and AI technology that can intelligently act on customer intent to improve customer experience with non-human engagement. Further, the company offers self-service GenAI and agentic AI assistants for applications in data analysis, language translations, and internal chatbots; voice of the customer and analytics solutions to gather and analyze customer feedback; analytics and consulting solutions that synthesize data and provide professional insight to improve clients' customer experience strategies; specialized support to specific industry verticals; and back office services that support clients in non-customer facing areas. It serves technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, healthcare, and other industries. The company was founded in 2004 and is based in Newark, California.
Why Investors Should Care
Revenue has grown at a 13.1% CAGR over the past five years.
Offers a dividend yield of 4.48%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Nov 2025 Revenue of $9.83B (+2.2% YoY); net profit $-1.28B.
- Trailing 12 Months Year-on-year growth — revenue +1.9%, earnings +36.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.05% |
| 1 Year: | 1.90% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 36.10% |
Stock Price Performance
| 1 Year: | -43.52% |
| 6 Months: | -14.16% |
| 3 Months: | +4.97% |
| 1 Month: | +9.91% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)52.24 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.1% over 5 years.
- Attractive dividend yield of 4.48%.
- Generates positive free cash flow.
CONS
- Trading 48.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CNXC Concentrix Corporation R3KTECHAI | 28.27 | -1.36 | $1.72B | 4.48% | -10.72% | -37.66% | 13.05% | - |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Feb 2020 | May 2020 | Aug 2020 | Feb 2021 | May 2021 | Aug 2021 | Feb 2022 | May 2022 | Aug 2022 | Feb 2023 | May 2023 | Aug 2023 | Feb 2024 | May 2024 | Aug 2024 | Feb 2025 | May 2025 | Aug 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.07B | 1.16B | 1.35B | 1.37B | 1.40B | 1.54B | 1.57B | 1.58B | 1.64B | 1.61B | 1.63B | 2.40B | 2.38B | 2.39B | 2.37B | 2.42B | 2.48B | 2.50B | 2.46B |
| Gross Profit | 445.19M | 345.17M | 412.53M | 486.05M | 482.73M | 481.34M | 538.13M | 558.92M | 566.85M | 581.16M | 580.23M | 593.69M | 856.53M | 857.57M | 864.19M | 855.90M | 848.15M | 855.01M | 849.66M | 823.35M |
| Operating Income | 88.21M | 23.58M | 76.76M | 134.89M | 128.22M | 151.38M | 147.75M | 156.91M | 157.54M | 156.05M | 162.57M | 162.27M | 148.44M | 150.17M | 153.24M | 168.87M | 148.34M | 146.98M | 118.56M | 95.42M |
| Net Income | 52.32M | 2.47M | 45.40M | 88.81M | 82.90M | 109.75M | 110.27M | 113.14M | 106.69M | 87.87M | 78.85M | 77.64M | 52.10M | 66.83M | 16.63M | 70.26M | 42.09M | 88.11M | 21.59M | 55.28M |
| Diluted EPS | 1.01 | 0.05 | 0.88 | 1.69 | 1.57 | 2.08 | 2.09 | 2.14 | 2.04 | 1.68 | 1.51 | 1.49 | 0.76 | 0.98 | 0.25 | 1.04 | 0.63 | 1.34 | 0.33 | 0.86 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.71B | 4.72B | 5.59B | 6.32B | 7.11B | 9.62B | 9.83B |
| Gross Profit | 1.75B | 1.66B | 1.97B | 2.26B | 2.58B | 3.45B | 3.44B |
| Operating Income | 294.33M | 308.76M | 572.40M | 640.19M | 661.33M | 596.39M | -918.18M |
| Net Income | 117.16M | 164.81M | 405.58M | 435.05M | 313.84M | 251.22M | -1.28B |
| Diluted EPS | 2.27 | 3.19 | 7.70 | 8.28 | 5.70 | 3.71 | -20.36 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Nov 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 5.18B | - | 6.67B | 12.49B | 11.99B | 10.76B |
| Current Assets | - | - | - | - | 1.75B | 2.86B | 2.84B | 3.08B |
| Cash & Equivalents | - | - | 152.66M | - | 145.38M | 295.34M | 240.57M | 327.35M |
| Inventory | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | 782.05M | 1.07B | 1.07B | 1.09B |
| Total Liabilities | - | - | 2.88B | - | 3.97B | 8.35B | 7.95B | 8.02B |
| Current Liabilities | - | - | 1.01B | - | 1.13B | 2.07B | 2.00B | 2.20B |
| Long Term Debt | - | - | 1.11B | - | 2.22B | 4.94B | 4.73B | 4.57B |
| Total Debt | - | - | - | - | 2.22B | 4.94B | 4.74B | 4.64B |
| Total Equity | 1.32B | 1.47B | 2.30B | - | 2.70B | 4.14B | 4.04B | 2.74B |
| Shares Outstanding | - | - | - | - | 52.37M | 67.88M | 68.85M | 70.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 449.74M | 507.61M | 514.18M | 600.72M | 678.01M | 667.49M | 806.97M |
| Investing Cash Flow | -151.01M | -109.22M | -78.65M | -1.84B | -2.11B | -244.27M | -250.38M |
| Financing Cash Flow | -339.64M | -335.22M | -401.87M | 1.24B | 1.80B | -492.53M | -491.44M |
| Capital Expenditure | -111.12M | -171.33M | -149.08M | -140.02M | -180.53M | -238.76M | -234.50M |
| Free Cash Flow | 338.61M | 336.28M | 365.10M | 460.70M | 497.48M | 428.73M | 572.47M |
| Share Buybacks | 0 | 0 | 25.10M | 120.82M | 63.96M | 136.10M | 168.71M |
| Dividends Paid | 0 | 0 | 13.08M | 53.43M | 63.49M | 83.81M | 89.62M |
Ratios (Annual)
Figures in %.
| Metric | Nov 2019 | Nov 2020 | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | 37.1% | 35.2% | 35.3% | 35.7% | 36.2% | 35.9% | 35.0% |
| Operating Margin % | 6.3% | 6.5% | 10.2% | 10.1% | 9.3% | 6.2% | -9.3% |
| Net Margin % | 2.5% | 3.5% | 7.3% | 6.9% | 4.4% | 2.6% | -13.0% |
| ROE % | 8.0% | 7.2% | - | 16.1% | 7.6% | 6.2% | -46.6% |
| ROCE % | - | 7.4% | - | 11.6% | 6.3% | 6.0% | -10.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.95% | 6.68M | $186.14M |
| 2 | FMR, LLC | 9.36% | 5.71M | $159.22M |
| 3 | Pzena Investment Management LLC | 5.59% | 3.41M | $95.14M |
| 4 | AQR Capital Management, LLC | 5.36% | 3.27M | $91.19M |
| 5 | Kopernik Global Investors, Llc | 5.20% | 3.18M | $88.51M |
| 6 | UBS Group AG | 5.19% | 3.17M | $88.28M |
| 7 | Vanguard Portfolio Management LLC | 4.68% | 2.86M | $79.61M |
| 8 | Groupe Bruxelles Lambert S.A. | 4.55% | 2.77M | $77.30M |
| 9 | Dimensional Fund Advisors LP | 4.31% | 2.63M | $73.26M |
| 10 | FIL LTD | 4.00% | 2.44M | $67.98M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CNXC
$CNXC stock is down 12% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxONXkwVTVvT091alJoMW5ka21adC1mMU5QekQyR3BJbGEzc0E5WDlobXlTYWlEb21MMHdnSmo0UXB2RHdfMXkyc1RtUE9rWngxcTlmVWlqeURIajZBUkF0cTVSYlRENE8wRDBpVzJuVXBjYm5FcHA1bW5nSWl5d3Y4UEdJM2dHQlpnSHRwbz…
AI-related risks are accelerating, Concentrix says. It buys CastleHill. - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNMnI1UnA2bWl4VE45c19HbXZZQ0hKamlnOWlnUzdtVkQ4d1hQNFlNVUxUSDhibVRKVldadjY2NUY2cHo5VHRSYVMtdkJ0d0RaajN6NWpUNVdqbDYzSVRBcGFTM09GWU55SGhEbG1GREVhQ2lUXy1zUEl3TkdpbjJIcnVNOXhlYWRaYUtEbH…
Third-quarter results are due Sept. 29 from Concentrix - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPemg2T2FCUDhQTzBPeW9HYlA4YTZxS1lCLWItSXNWX2huZERobUhIekZJYUd5cjBPUDBycHhEM0NHT2oyb0dmYVJSdU0wNElDMm5vT1plWGxnTFBPSmxGRExfZWRnNkNwQzQ1VHRBYkhuRnoycjFOOEdPM3NpLTlLaXRWcWN0N296T1h1TW…
3 Reasons to Avoid CNXC and 1 Stock to Buy Instead - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQQnNneW4xRFVsRWtKdHFFU0hla2dGbHZQakZ1aTFqTXhLUkhwOWJlX2ZRWkNHNTdMNWl2R2xVZ1dXdjg5NjNkTmtWYjJRYlN2eTVzNDVHTDhMZExaeXd5ZzR1dlFNMXBIX2Y5UDR5bnBHblFYcXBpdEViZzA5UHY4VDVnY3Y4b3RfNkdFR3…
Why Concentrix (CNXC) Shares Are Getting Obliterated Today - StockStory
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOOGNkS2JBNHBXUVg2S1p4T0lES19yQktYbUpOd243dDdXamdyLTR6aEt1cDV2TG5tbzhEMVplSmhFRm42bkp2NFFoYkYxMGtzaHM1THpQYVdsa1htazZLeDJSd1UxR0JDRzN0cXlkYlZDREZIaEZhQzNiX0VmdGRkaDNWWEljV2hZU3JGWV…
CNXC Stock Hit Record Lows After Q2 Report Fails To Impress Investors – Here’s What Wall Street Had To Say - TradingView
<a href="https://news.google.com/rss/articles/CBMi9wFBVV95cUxNRjBpX2pxaTVVSDZuLW9lWmoyTVBHMFAxV1VpUk53MFZva1F2N20yczFMS2hqcDZYXzJOb20yY3hWVnR2alM3T184ZWJTMHhXX1NFZVhmdjNnQlVvaU9paW15X1lyTXYtUU5YSWhrcVlXV2loUEZnT04tTWZOdlNlYWRZRkRTdVlXM1Y1cn…
CNXC — Frequently Asked Questions
What is the current share price of Concentrix Corporation (CNXC)?
As of 2026-09-19 21:16 PDT, Concentrix Corporation (CNXC) trades at $28.27 on NasdaqGS. Its 52-week range is $20.63 to $54.48.
What is the market capitalisation of CNXC?
Concentrix Corporation (CNXC) has a market capitalisation of $1.72B on NasdaqGS.
What is the P/E ratio of CNXC?
CNXC trades at a trailing price-to-earnings (P/E) ratio of -1.36. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 0.61.
Does CNXC pay a dividend?
Concentrix Corporation (CNXC) currently offers a dividend yield of 4.48%.
What is the return on equity (ROE) of CNXC?
CNXC has a return on equity (ROE) of -37.66%. Its return on capital employed (ROCE) is -10.72%.
Is CNXC a good stock to buy?
This page provides a data-driven analysis of Concentrix Corporation (CNXC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.